RxDoctor Payments Data

Govind Acharya, MD

Plastic Surgery · Phoenix, AZNPI 1487716692

Payments from drug & device makers

What this record shows

This record is dominated by other: $10,000 of the $14,979 with a category attached, or 66.8%. Angiodynamics, Inc. accounts for 80.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $10,220 and has fallen 99.7% since, to $27 in 2024. Among plastic surgery clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,979in general payments, 2019–2025

Across 62 payments — averaging $241.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$12K
  • AbbVie$2K
  • Smith+Nephew$379
  • Sientra, Inc.$195
  • Integra Lifesciences Corporation$142
  • Organogenesis Inc.$134
  • plus $489 from 9 others

What the payments were for

  • Speaking & faculty fees$861%
  • Travel & lodging$6895%
  • Food & beverage$2,55317%
  • Education$1,65011%
  • Other$10,00067%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,979 in reported general payments places this provider in the 90th percentile of 123 plastic surgery providers in Arizona.

See all plastic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$15,073
Medicare patients
14
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine16$288
Silver Sulfadiazine15$181

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →